DexCom Other Non-Current Liabilities 2010-2025 | DXCM

DexCom other non-current liabilities for the quarter ending June 30, 2025 were $0.152B, a 18.35% increase year-over-year.

  • DexCom other non-current liabilities for 2024 were $0.148B, a 17.75% increase from 2023.
  • DexCom other non-current liabilities for 2023 were $0.126B, a 2.1% decline from 2022.
  • DexCom other non-current liabilities for 2022 were $0.128B, a 42.56% increase from 2021.

DexCom Other Non-Current Liabilities 2010-2025 | DXCM

  • DexCom other non-current liabilities for 2024 were $0.148B, a 17.75% increase from 2023.
  • DexCom other non-current liabilities for 2023 were $0.126B, a 2.1% decline from 2022.
  • DexCom other non-current liabilities for 2022 were $0.128B, a 42.56% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$184.1B
Intuitive Surgical (ISRG)$172.5B
IDEXX Laboratories (IDXX)$51B
Edwards Lifesciences (EW)$46B
Alcon (ALC)$43.5B
IQVIA Holdings (IQV)$32.7B
Mettler-Toledo (MTD)$27B
STERIS (STE)$24.1B
Waters (WAT)$17.2B
SONOVA HOLDING (SONVY)$16.8B
Hologic (HOLX)$15B
Penumbra (PEN)$10B
Sysmex ADR (SSMXY)$8.4B
Masimo (MASI)$8.4B
Globus Medical (GMED)$8.1B
Teleflex (TFX)$5.3B
Glaukos (GKOS)$5.1B
TransMedics (TMDX)$4.3B
Integer Holdings (ITGR)$3.7B
LivaNova (LIVN)$2.9B
Veracyte (VCYT)$2.4B
Alphatec Holdings (ATEC)$2.3B
PROCEPT BioRobotics (PRCT)$2.3B
Artivion (AORT)$2B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.8B
OPKO Health (OPK)$1.1B
Paragon 28 (FNA)$1.1B
Integra LifeSciences Holdings (IART)$1.1B
Pulse Biosciences (PLSE)$1.1B